TriangleMR-guided Stereotactic Body… (NCT07635238)
MR-guided Stereotactic Body Radiation Therapy trial for Prostate Cancer (NCT07635238). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adult men with prostate adenocarcinoma, grade groups one to three, PSA below twenty nanograms/milliliter, and no nodal or distant spread. MRI-visible, biopsy-confirmed tumors must meet targeting limits.
The idea: random assignment compares uniform prostate radiation with lower doses in parts. Both receive two MRI-guided treatments. Researchers measure urinary side effects. Hormone therapy is optional when normally indicated, but needing more than six months excludes participation. Prior local prostate treatment is excluded.
This phase 2 study plans 54 patients. Victoria Brennan leads at MSK, New York; seven US sites recruit.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.